Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
130.40    0.00 (0.00%)
Bid:
130.00
Ask:
130.80
Spread: 0.80 (0.615%)
Market Cap: £317.42m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

3 Nov 2023 07:05

RNS Number : 2548S
PureTech Health PLC
03 November 2023
 

3 November 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

2 November 2023

Number of ordinary shares purchased:

35,710

Highest price paid per share:

161.40p

Lowest price paid per share:

154.60p

Volume weighted average price paid per share:

157.86p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,046,553 ordinary shares in treasury and has 273,421,606 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,421,606 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

02/11/2023

09:07:03

112

156.2

XLON

00376746544TRLO0.1.1

02/11/2023

09:07:36

337

156.2

XLON

00376746730TRLO0.1.1

02/11/2023

09:07:36

112

156.2

XLON

00376746731TRLO0.1.1

02/11/2023

09:08:23

125

156.2

XLON

00376746989TRLO0.1.1

02/11/2023

09:09:15

316

156.2

XLON

00376747266TRLO0.1.1

02/11/2023

09:09:15

302

156.2

XLON

00376747265TRLO0.1.1

02/11/2023

09:09:34

2436

154.8

XLON

00376747347TRLO0.1.1

02/11/2023

09:12:52

748

154.6

CHIX

00376748539TRLO0.1.1

02/11/2023

09:12:52

374

154.6

XLON

00376748540TRLO0.1.1

02/11/2023

10:00:28

1496

159.8

XLON

00376765495TRLO0.1.1

02/11/2023

10:00:28

169

159.8

BATE

00376765496TRLO0.1.1

02/11/2023

10:00:28

23

159.8

BATE

00376765497TRLO0.1.1

02/11/2023

10:23:03

182

159.8

BATE

00376770908TRLO0.1.1

02/11/2023

10:23:03

374

160

CHIX

00376770907TRLO0.1.1

02/11/2023

10:23:03

1496

159.8

XLON

00376770909TRLO0.1.1

02/11/2023

10:23:06

196

159.6

AQXE

00376770924TRLO0.1.1

02/11/2023

10:23:06

15

159.6

AQXE

00376770925TRLO0.1.1

02/11/2023

12:04:06

374

161.4

CHIX

00376793494TRLO0.1.1

02/11/2023

12:04:06

238

161.4

BATE

00376793495TRLO0.1.1

02/11/2023

12:04:06

66

161.4

BATE

00376793496TRLO0.1.1

02/11/2023

12:59:30

374

161.4

CHIX

00376805106TRLO0.1.1

02/11/2023

12:59:30

211

161.4

AQXE

00376805105TRLO0.1.1

02/11/2023

13:00:32

748

160

XLON

00376805316TRLO0.1.1

02/11/2023

13:04:38

14

158.6

TRQX

00376806120TRLO0.1.1

02/11/2023

13:04:38

1

158.6

TRQX

00376806122TRLO0.1.1

02/11/2023

13:04:38

51

158.6

TRQX

00376806121TRLO0.1.1

02/11/2023

13:30:45

34

158.8

XLON

00376813420TRLO0.1.1

02/11/2023

13:30:45

374

158.8

XLON

00376813421TRLO0.1.1

02/11/2023

13:30:45

592

158.8

XLON

00376813422TRLO0.1.1

02/11/2023

13:30:45

122

158.8

XLON

00376813423TRLO0.1.1

02/11/2023

13:30:45

748

158.8

XLON

00376813424TRLO0.1.1

02/11/2023

13:30:45

444

158.8

BATE

00376813425TRLO0.1.1

02/11/2023

13:30:45

14

158.6

TRQX

00376813426TRLO0.1.1

02/11/2023

13:36:18

374

158

XLON

00376819988TRLO0.1.1

02/11/2023

13:36:18

360

158

XLON

00376819989TRLO0.1.1

02/11/2023

13:36:24

14

158

XLON

00376820092TRLO0.1.1

02/11/2023

13:40:52

374

158.2

XLON

00376826644TRLO0.1.1

02/11/2023

13:40:52

10

158.2

XLON

00376826645TRLO0.1.1

02/11/2023

13:40:52

364

158.2

XLON

00376826646TRLO0.1.1

02/11/2023

13:40:54

80

158.2

TRQX

00376826677TRLO0.1.1

02/11/2023

13:43:30

211

157.6

AQXE

00376832340TRLO0.1.1

02/11/2023

14:00:37

374

158.6

CHIX

00376849698TRLO0.1.1

02/11/2023

14:00:40

748

158.4

XLON

00376849718TRLO0.1.1

02/11/2023

14:00:40

284

158.4

XLON

00376849719TRLO0.1.1

02/11/2023

14:00:40

748

158.4

XLON

00376849720TRLO0.1.1

02/11/2023

14:09:04

374

158.2

BATE

00376856302TRLO0.1.1

02/11/2023

14:09:04

58

158.2

TRQX

00376856303TRLO0.1.1

02/11/2023

14:09:04

22

158.2

TRQX

00376856304TRLO0.1.1

02/11/2023

14:37:41

80

158.4

TRQX

00376884746TRLO0.1.1

02/11/2023

14:54:25

374

158.8

CHIX

00376897254TRLO0.1.1

02/11/2023

15:00:30

211

158.2

AQXE

00376901976TRLO0.1.1

02/11/2023

15:00:30

211

158.2

AQXE

00376901977TRLO0.1.1

02/11/2023

15:00:30

55

158.2

XLON

00376901978TRLO0.1.1

02/11/2023

15:00:32

13

158.2

BATE

00376902011TRLO0.1.1

02/11/2023

15:00:32

361

158.2

BATE

00376902010TRLO0.1.1

02/11/2023

15:00:32

374

158.2

CHIX

00376902013TRLO0.1.1

02/11/2023

15:00:32

374

158.2

BATE

00376902012TRLO0.1.1

02/11/2023

15:00:32

748

158.2

XLON

00376902015TRLO0.1.1

02/11/2023

15:00:32

1441

158.2

XLON

00376902014TRLO0.1.1

02/11/2023

15:00:32

80

158.2

TRQX

00376902016TRLO0.1.1

02/11/2023

15:00:32

374

158

XLON

00376902017TRLO0.1.1

02/11/2023

15:14:34

211

157.2

AQXE

00376912924TRLO0.1.1

02/11/2023

15:14:34

268

157.6

CHIX

00376912925TRLO0.1.1

02/11/2023

15:14:34

118

157

BATE

00376912926TRLO0.1.1

02/11/2023

15:14:34

374

157

BATE

00376912927TRLO0.1.1

02/11/2023

15:14:34

80

156.8

TRQX

00376912929TRLO0.1.1

02/11/2023

15:14:34

1

157

BATE

00376912928TRLO0.1.1

02/11/2023

15:14:34

1496

157.6

XLON

00376912939TRLO0.1.1

02/11/2023

15:14:35

156

157.4

XLON

00376912967TRLO0.1.1

02/11/2023

15:14:35

331

157.4

XLON

00376912966TRLO0.1.1

02/11/2023

15:25:47

503

159

XLON

00376922803TRLO0.1.1

02/11/2023

15:25:47

1145

159.2

XLON

00376922804TRLO0.1.1

02/11/2023

15:25:47

2830

159.2

XLON

00376922805TRLO0.1.1

02/11/2023

16:03:03

80

156.8

TRQX

00376947816TRLO0.1.1

02/11/2023

16:18:00

114

156

AQXE

00376958641TRLO0.1.1

02/11/2023

16:18:00

211

156

AQXE

00376958640TRLO0.1.1

02/11/2023

16:18:00

387

156

BATE

00376958643TRLO0.1.1

02/11/2023

16:18:00

97

156

AQXE

00376958642TRLO0.1.1

02/11/2023

16:18:01

372

156

CHIX

00376958652TRLO0.1.1

02/11/2023

16:18:01

58

156

CHIX

00376958653TRLO0.1.1

02/11/2023

16:18:01

108

156

CHIX

00376958654TRLO0.1.1

02/11/2023

16:18:01

77

156

BATE

00376958656TRLO0.1.1

02/11/2023

16:18:01

75

156

BATE

00376958655TRLO0.1.1

02/11/2023

16:18:01

90

156

BATE

00376958657TRLO0.1.1

02/11/2023

16:18:01

181

156

CHIX

00376958662TRLO0.1.1

02/11/2023

16:18:01

135

156

CHIX

00376958661TRLO0.1.1

02/11/2023

16:18:01

80

156

TRQX

00376958663TRLO0.1.1

02/11/2023

16:18:01

46

156

TRQX

00376958664TRLO0.1.1

02/11/2023

16:18:01

34

156

TRQX

00376958665TRLO0.1.1

02/11/2023

16:18:02

895

156

XLON

00376958694TRLO0.1.1

02/11/2023

16:18:04

165

156

XLON

00376958733TRLO0.1.1

02/11/2023

16:18:04

1000

156

XLON

00376958734TRLO0.1.1

02/11/2023

16:18:04

184

156

XLON

00376958735TRLO0.1.1

02/11/2023

16:18:04

298

155.8

XLON

00376958736TRLO0.1.1

02/11/2023

16:20:05

374

155.4

BATE

00376960317TRLO0.1.1

02/11/2023

16:29:34

215

155.8

CHIX

00376967549TRLO0.1.1

02/11/2023

16:29:38

212

155.8

CHIX

00376967722TRLO0.1.1

02/11/2023

16:29:43

35

157.4

AQXE

00376967840TRLO0.1.1

02/11/2023

16:29:54

189

157.4

AQXE

00376968154TRLO0.1.1

02/11/2023

16:29:54

176

157.4

AQXE

00376968153TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFSDLILFIIV
Date   Source Headline
10th Jun 20265:38 pmRNSResult of AGM
9th Jun 20267:00 amRNS-RPRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.